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D E S C R I P T I O N  O F  C A S E
A 69-year-old female presented with palpitations and a history of tiredness and shortness of breath for several weeks. She had a previous history of Raynaud 
syndrome. She was an ex-smoker. She commented that she 
had not lost her tan since the previous summer. Her only 
medication was nifedipine for her Raynaud syndrome.
On examination, she was slim and tanned. Pulse rate was 
86 beats per minute  and regular. Her blood pressure (BP) 
was 105/74 mm Hg. Her chest was hyperinfl ated. The rest 
of her examination was recorded as normal. A chest X ray 
showed no evidence of cardiac failure. Electrocardiogram 
monitoring showed episodes of atrial fi brillation. Her routine 
biochemistry was as follows: serum sodium, 132 mmol/l 
(normal range, 135–145 mmol/l); potassium, 5.1 mmol/l 
(3.4–5 mmmol/l); urea, 8.6 mmol/l (2.5–6.4 mmol/l); and 
creatinine, 110 mmol/l (65–120 µmol/l).
She was commenced on digoxin and warfarin. Her 
breathlessness gradually improved, and she remained in sinus 
rhythm.
How Would You Explain the Hyponatraemia, 
and What Additional Investigations Are Required?
Hyponatraemia is a common electrolyte abnormality 
in hospitalised patients [1]. The cause is often obvious 
(e.g., a clear history of fl uid and electrolyte loss through 
vomiting or diarrhoea, or through use of thiazides or 
loop diuretics). A patient with hyponatraemia should be 
assessed by fi rst taking a thorough history, focusing on 
gastrointestinal symptoms, fl uid intake, thirst, postural 
dizziness, and medication. Evidence of intravascular volume 
depletion should be sought by examining skin turgour, the 
tongue, jugular venous pressure, and pulse rate, and most 
importantly, by measuring the BP in the supine and erect 
positions. A drop of BP by more than 20 mm Hg is indicative 
of intravascular volume depletion. Measurement of urinary 
sodium is the single most useful test. A urinary sodium 
concentration less than 20 mmol/l is indicative of volume 
depletion due to extrarenal causes (except in certain 
oedematous states). A urinary sodium concentration greater 
than 40 mmol/l suggests syndrome of inappropriate ADH 
secretion (SIADH), or a salt-losing nephropathy (diuretics, 
primary renal tubular diseases, or adrenal failure). The 
diagnosis of SIADH requires demonstration of normal 
thyroid and adrenocortical function, in the absence of 
intravascular volume depletion [2].
Progress
The patient was admitted into hospital two weeks after the 
initial presentation. Her main complaints were increasing 
lethargy and tiredness, reduced appetite, an episode of 
fainting, and weight loss. On examination, she was pigmented 
and thin (Figures 1 and 2). Her pulse rate was 76 beats per 
minute in sinus rhythm. BP was 77/59 mm Hg. The rest of 
the examination was normal.
What Is the Differential Diagnosis?
A history of malaise, anorexia, and weight loss in a 69-year-old 
patient is worrisome, and malignancy requires exclusion. She 
is an ex-smoker; therefore, lung cancer should be considered. 
SIADH can be a complication of lung cancer, and she has a 
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Figure 1. The Patient’s Facial Appearance at Presentation versus after 
Treatment
Facial appearance at presentation (left), showing pigmentation, and 
after treatment (right).
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history of hyponatraemia. Pigmentation may also occur 
in some lung cancers and other malignancies associated 
with ectopic adrenocorticotrophic hormone (ACTH) 
production. However, ectopic ACTH is usually associated 
with hypokalaemia and hypertension, which have not been 
features in this patient. 
Lung, breast, gastrointestinal, and other malignancies can 
cause hypercalcaemia due to parathyroid hormone–related 
peptide secretion, and common symptoms of hypercalcaemia 
include anorexia, lethargy, and dehydration. 
The patient has recently been started on digoxin, and 
toxicity from this drug can manifest as anorexia and malaise. 
The recent introduction of warfarin may also have led to 
occult blood loss, which could account for her malaise and 
hypotension. 
Generalised pigmentation can be a manifestation of 
other systemic disorders. The patient is known to have 
Raynaud syndrome, and systemic sclerosis is associated with 
both Raynaud and pigmentation but is rare, and she has 
no other features, such as arthropathy or vasculitic lesions. 
Haemochromatosis can cause pigmentation and present 
with malaise due to liver failure, diabetes, or other rarer 
endocrinopathies, and predisposes a patient to hepatocellular 
carcinoma. Thyrotoxicosis and type 1 diabetes sometimes 
present in an atypical manner in patients of this age group, 
and need to be excluded. Primary adrenal failure could 
explain the patient’s anorexia, malaise, pigmentation, low 
blood pressure, fainting, and serum electrolytes.
If you suspected primary adrenal failure, the specifi c 
symptoms that you would ask about are shown in Box 1.
Investigations following the Second Hospital 
Admission
Following the second hospital admission, the chest X ray 
was unchanged from previous, with no masses. Other 
investigations had the following results:  electrocardiogram, 
sinus rhythm, no digoxin effect; creatinine, 87 mmol/l 
(65–120 µmol/l); plasma glucose, 3.4 mmol/l; potassium, 
5.4 mmol/l (3.4–5 mmol/l); sodium, 113 mmol/l (135–145 
mmol/l); urea, 5.2 mmol/l (2.5–6.4 mmol/l); urine sodium, 
45 mmol/l; serum thyroid-stimulating hormone, 7.87 mU/l 
(0.3–4.1 mU/l); serum free thyroxine, 18 pmol/l (11–23 
pmol/l). Serum calcium, haemoglobin, and liver function 
tests were normal. Ultrasound scan of the abdomen was 
normal. Autoantibodies and extractable nuclear antigen 
Scl70 were negative; extractable-nuclear-antigen ribonucleic 
proteins were positive; thyroid microsomal antibodies were 
positive with a titre greater than 1/800; and antinuclear 
antibodies were negative. 
How Would You Manage the Patient’s Hyponatraemia?
This patient now has developed severe hyponatraemia and is 
at risk of developing neurological problems (deterioration 
in level of consciousness, and fi ts); therefore, treatment 
is required as a matter of urgency. Correct management 
depends on the cause. If the diagnosis is SIADH, the patient 
needs to be fl uid restricted; if it is volume depletion, she will 
require intravenous fl uid and electrolytes. 
The low BP and high potassium are against a diagnosis of 
SIADH. It can be argued that salt and water depletion that is 
suffi cient to cause severe hyponatraemia would be expected 
to be associated with a higher level of urea. Serum urea, 
however, is also dependent on the patient’s muscle mass, 
which in this case was low. SIADH usually is associated with 
a urea level of less than 4 mmol/l. The high level of urine 
sodium is consistent with SIADH, but also with salt loss from 
the kidneys. 
The diagnosis, therefore, is volume depletion due to 
renal losses, and normal saline should be administered 
intravenously.
The rapidity by which hyponatraemia is corrected is 
crucial. If the serum sodium is corrected too quickly and 
the hyponatraemia is chronic, there is a risk of central 
pontine myelinolysis [3]. Frequent monitoring of serum 
sodium, aiming for a rise of serum sodium of no more than 
10 mmol/l/d, should be undertaken when the duration 
of hyponatraemia is chronic or unknown [2]. In patients 
where the hyponatraemia is known to have developed within 
the previous 2–3 days, it can be corrected fast, if there is an 
indication for doing so (coma or fi ts).
Box 1. Common Symptoms of Primary Adrenal 
Failure
• Tiredness
• Anorexia
• Nausea and vomiting
• Abdominal pain
• Weight loss
• Postural dizziness
• Pigmentation
• Craving for salt
• Weakness
• Hypoglycaemic episodes
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Figure 2. Photo of the Patient’s Hand at Presentation, Showing 
Pigmentation in the Creases
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How Would You Explain the Other Laboratory 
Abnormalities?
Antibodies to extractable-nuclear-antigen ribonucleic 
protein are associated with mixed connective tissue disorder, 
but the specifi city of the test is only 60%–75% [4].  The 
diagnosis of mixed connective tissue disorder requires 
additional clinical features that this patient did not have, 
although the positive antibodies to extractable-nuclear-
antigen ribonucleic protein indicate that this patient has an 
autoimmune predisposition.
The patient’s thyroid blood tests show a raised serum 
thyroid-stimulating hormone and normal free thyroxine, a 
condition often referred to as “subclinical” hypothyroidism. 
Her thyroid microsomal antibodies are also markedly positive 
and suggest an underlying autoimmune thyroiditis.
What Tests Are Required to Confi rm Primary Adrenal 
Failure (Addison Disease)?
The biochemical diagnosis of Addison disease is made 
by measuring the serum cortisol concentration. Cortisol 
is a stress hormone with a prominent diurnal variation, 
consisting of an early morning peak and low levels in the 
evening and early part of the night. A single, random cortisol 
measurement, therefore, may not be diagnostic, unless the 
patient is physiologically stressed at the time (for example, 
patients presenting with an adrenal crisis can be diagnosed 
by a random cortisol measurement taken at the time of their 
illness and before steroid therapy is initiated). Hypotensive 
patients with an intact adrenal axis are expected to have 
a serum cortisol greater than 550 mmol/l; therefore, a 
cortisol concentration signifi cantly lower than that, in such 
circumstances, is inappropriate. A blood sample should also 
be taken for plasma ACTH, which will indicate whether the 
hypoadrenalism is due to primary adrenal disease (high 
ACTH) or hypothalamic/pituitary disease (low ACTH). 
Measurement of the plasma renin activity and aldosterone 
concentrations is also helpful: in Addison disease plasma 
renin activity is high (because of the low intravascular 
volume) and plasma aldosterone is low (because of inability 
of the adrenal cortex to produce it). 
In more stable or ambulant patients, a short synacthen 
test is usually diagnostic. The criterion for a normal 
synacthen test is a 30-minute cortisol value of more than 
550 mmol/l [5]. The protocol for a short synacthen test 
is shown in Box 2.
This patient had a short synacthen test, and the results 
were as follows: cortisol at baseline, 135 mmol/l; cortisol at 30 
minutes, 144 mmol/l; baseline ACTH, 434 pg/l (0–47 pg/l); 
plasma renin activity, 8.9 ng/ml/h (1.1–4.1 ng/ml/h); and 
aldosterone, <50 pmol/l (220–430 pmol/l). 
What Steroid Regimen Should the Patient Have 
at This Stage?
Patients in adrenal crisis or those who are hypotensive 
or cannot take medication orally should have parenteral 
glucocorticoid, in addition to saline and dextrose. In such 
a scenario, hydrocortisone is administered intravenously 
or intramuscularly by multiple bolus injections or by 
continuous infusion. A common regimen is 100–150 mg of 
hydrocortisone daily, until the patient’s condition improves 
[6]. With such supraphysiological doses of glucocorticoids, 
no mineralocorticoid is required. If the patient is not acutely 
ill and is able to take steroids orally, hydrocortisone may be 
given initially at a dose of 40 mg in the morning and 20 mg 
in the evening. Once the patient’s condition is improved 
(usually 3-4 days), the dose of hydrocortisone is reduced to 
20–30 mg daily in two or three divided doses, with one-half 
to two-thirds of the dose taken on rising in the morning and 
the rest at noon and in the early evening. Mineralocorticoid is 
usually also introduced at this stage (fl uodrocortisone 50–100 
mg daily, as a single dose).
What Additional Investigations Are Required?
The cause of Addison disease needs to be identifi ed. 
Autoimmune adrenalitis is the most common cause in the 
developed world, but infectious diseases like tuberculosis and 
fungal infection are common in some areas [7]. In an older 
age group, metastases to the adrenal glands are a possibility. 
Haemorrhage into the adrenals or infarction can occur in the 
context of meningococcal septicaemia, overanticoagulation, 
and antiphospholid syndrome. 
In this case, adrenal antibodies were strongly positive and 
an ultrasound of the abdomen showed no abnormalities; 
therefore, more investigations were not undertaken. If 
imaging of the adrenals is specifi cally indicated, computerised 
tomography scanning is the best modality.
Should the Hypothyroidism Be Corrected by Adding 
Thyroxine?
Autoimmune hypoadrenalism and thyroid disease often 
coexist. It is imperative that the adrenal failure is treated 
fi rst, as thyroxine replacement in an undiagnosed patient 
with Addison disease can precipitate a crisis [8]. Often, 
mild abnormalities in thyroid function (subclinical 
hypothyroidism) resolve after initiation of steroid therapy 
without thyroid replacement, as was the case in this patient.
D I S C U S S I O N
Addison disease usually presents with nonspecifi c symptoms 
and should be considered in patients with unexplained 
malaise. Pigmentation, when present, is an important clue 
to the diagnosis. Hyponatraemia is almost invariable, though 
it may be mild and easily missed, as it is a common fi nding 
in hospitalised patients. Hyponatraemia merits investigation 
to reveal the underlying cause, as the treatments may be 
very different—fl uid restriction if due to SIADH and fl uid 
administration if due to fl uid and electrolyte depletion. If 
the hyponatraemia is chronic, correction should be slow and 
closely supervised. Subclinical hypothyroidism may coexist 
with Addison disease. As thyroid disease is much more 
common than Addison disease and thyroid function tests 
Box 2. Protocol for Short Synacthen Test
1. Test is best performed in the morning, e.g., at 9:00 am. 
2. Insert intravenous cannula.
3. Take basal cortisol, ACTH, renin, aldosterone, urea and 
electrolytes, and adrenal antibodies.
4. Short synacthen, 250 µg, is given as intravenous bolus at time 
zero.
5. Take samples at 0, 30, and 60 minutes for cortisol.
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are frequently requested, the patient’s symptoms may be 
attributed to the thyroid dysfunction. Initiation of thyroxine 
therapy in such cases can precipitate an adrenal crisis, and 
physicians should think about Addison disease in patients 
whose symptoms deteriorate after thyroxine. 
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Key Learning Points
• Think of Addison disease in patients complaining of tiredness 
and who look genuinely ill.
• Check supine and erect BP in hyponatraemic cases.
• The most useful biochemical test in assessing hyponatraemia 
is the urine sodium.
• The diagnosis of SIADH requires exclusion of adrenal and 
thyroid failure.
• An inappropriately low serum cortisol in a critically ill patient 
may be diagnostic of hypoadrenalism.
• The defi nitive diagnostic test for Addison disease is the short 
synacthen test.
Once primary adrenal failure is diagnosed, look for the 
underlying cause.
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